JaspreetSinghGrewalMDPhD

Oncology • Louisville, KY

Physician

Join to view full profile

Dr. Grewal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grewal's full profile

Already have an account?

Office
529 S Jackson St
Louisville, KY 40202
Phone+1 502-562-4370

Fax+1 502-217-5141

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
Trinity Health Ann Arbor HospitalResidency, Internal Medicine, 2005 - 2008
Christian Medical College LudhianaClass of 2002
University of Illinois at ChicagoMPH
Michigan State UniversityMS
University of LouisvillePhD

Certifications & Licensure

IN State Medical License 2018 - 2025
KY State Medical License 2012 - 2025
ME State Medical License 2018 - 2019
MA State Medical License 2017 - 2018
MI State Medical License 2005 - 2015
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09
Recruiting
Phase 1, Phase 2
Roles: Contact
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Feb 25
Recruiting
Phase 1
Roles: Principal Investigator

Publications & Presentations

PubMed

Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab ...
Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani, Justin Moser, Michael Millward
Journal for Immunotherapy of Cancer. 2024-08-03
4 citations
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Guru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X Wei, Kerry L Kilbridge
Cancer Immunology, Immunotherapy. 2023-03-01
309 citations
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Mary L. Disis, Matthew H. Taylor, Karen Kelly, J. Thaddeus Beck, Michael S. Gordon
JAMA Oncology. 2019-03-01

Press Mentions

Knowde Group Inc.™ Enters into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical TrialsJuly 19th, 2021

Other Languages

Hindi, Punjabi, Urdu